Anti-Diabetic Potential of Gamochaeta pensylvanica (Willd.) Cabrera Extracts: In Vitro Enzyme Inhibition and In Vivo Evaluation in Streptozotocin–Nicotinamide-Induced Diabetic Rats
Journal of Pharmaceutical Innovation · 2026-08 · 21 (4)
DOI: 10.1007/s12247-026-10592-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmaceutical Innovation, online erschienen am 21.03.2026. Verfasst von Hemanta Kumar Gogoi und 6 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Gogoi, H. K., Boruah, P., Das, S. R. C., Das, T., Kar, K., Chowdhury, S., & Chakraborty, P. (2026). Anti-Diabetic Potential of Gamochaeta pensylvanica (Willd.) Cabrera Extracts: In Vitro Enzyme Inhibition and In Vivo Evaluation in Streptozotocin–Nicotinamide-Induced Diabetic Rats. Journal of Pharmaceutical Innovation, 21(4). https://doi.org/10.1007/s12247-026-10592-0
Vancouver
Gogoi HK, Boruah P, Das SRC, Das T, Kar K, Chowdhury S, et al. Anti-Diabetic Potential of Gamochaeta pensylvanica (Willd.) Cabrera Extracts: In Vitro Enzyme Inhibition and In Vivo Evaluation in Streptozotocin–Nicotinamide-Induced Diabetic Rats. Journal of Pharmaceutical Innovation. 2026;21(4). doi:10.1007/s12247-026-10592-0
BibTeX
@article{Gogoi2026,
author = {Gogoi, Hemanta Kumar and Boruah, Priyanka and Das, Smriti Rekha Chanda and Das, Trishna and Kar, Koyel and Chowdhury, Sailee and Chakraborty, Priyanka},
title = {Anti-Diabetic Potential of Gamochaeta pensylvanica (Willd.) Cabrera Extracts: In Vitro Enzyme Inhibition and In Vivo Evaluation in Streptozotocin–Nicotinamide-Induced Diabetic Rats},
journal = {Journal of Pharmaceutical Innovation},
year = {2026},
volume = {21},
number = {4},
doi = {10.1007/s12247-026-10592-0}
}
EUVIMED